Literature DB >> 16196491

Role of molecular interaction in stability of celecoxib-PVP amorphous systems.

Piyush Gupta1, R Thilagavathi, Asit K Chakraborti, Arvind K Bansal.   

Abstract

Stabilization of an amorphous solid against devitrification can be achieved using additives that interact specifically with the parent molecule, and restrain it from rearranging into a crystal lattice. The amorphous form of celecoxib (CEL) was stabilized by poly(vinylpyrrolidone) (PVP), both in the solid state and during dissolution. A comprehensive characterization of CEL-PVP binary amorphous systems by thermal, spectroscopic, and computer simulation techniques provided greater insight into the molecular interaction between the two species. PVP antiplasticized the amorphous CEL, thus raising its glass transition temperature (T(g)) and restricting the molecular mobility. The T(g)()mix values for CEL-PVP binary amorphous systems of varying composition showed positive deviation from those predicted through the Gordon-Taylor/ Kelley-Bueche equation, thus indicating a molecular interaction between CEL and PVP. This was further substantiated by shifts observed in DSC melting endotherms of CEL, and FTIR bands for C=O stretching vibrations in PVP for CEL-PVP binary amorphous systems. Computer simulation showed stronger H-bonds between amido protons of CEL and carbonyl O of a monomeric unit of PVP, compared to those observed in pure amorphous CEL. These molecular interactions between CEL and PVP supported the stabilizing action of PVP for the amorphous form of CEL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16196491     DOI: 10.1021/mp050004g

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  8 in total

1.  Theoretical study of hydrogen bond interactions of fluvastatin with ι-carrageenan and λ-carrageenan.

Authors:  Anastasios G Papadopoulos; Michael P Sigalas
Journal:  J Mol Model       Date:  2010-10-28       Impact factor: 1.810

2.  Characterization of amorphous celecoxib mixed with plasticizing (TPGS) and anti-plasticizing (PVP) ingredients using Hot Melt Extrusion.

Authors:  Darlene Santiago; Adlin Mendoza; Zuleyka Morales; Javier Santos
Journal:  J Pharm Innov       Date:  2019-03-13       Impact factor: 2.750

3.  Preparation and characterization of celecoxib dispersions in soluplus(®): comparison of spray drying and conventional methods.

Authors:  Alireza Homayouni; Fatemeh Sadeghi; Ali Nokhodchi; Jaleh Varshosaz; Hadi Afrasiabi Garekani
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

4.  Myth or Truth: The Glass Forming Ability Class III Drugs Will Always Form Single-Phase Homogenous Amorphous Solid Dispersion Formulations.

Authors:  Piyush Panini; Massimiliano Rampazzo; Abhishek Singh; Filip Vanhoutte; Guy Van den Mooter
Journal:  Pharmaceutics       Date:  2019-10-14       Impact factor: 6.321

5.  Solubility Improvement of Progesterone from Solid Dispersions Prepared by Solvent Evaporation and Co-milling.

Authors:  Xing Chen; Ioannis Partheniadis; Ioannis Nikolakakis; Hisham Al-Obaidi
Journal:  Polymers (Basel)       Date:  2020-04-07       Impact factor: 4.329

6.  Formulation and In Vitro Characterization of a Vacuum-Dried Drug-Polymer Thin Film for Intranasal Application.

Authors:  Daisuke Inoue; Ayari Yamashita; Hideto To
Journal:  Polymers (Basel)       Date:  2022-07-21       Impact factor: 4.967

7.  Preparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers.

Authors:  Alireza Homayouni; Fatemeh Sadeghi; Ali Nokhodchi; Jaleh Varshosaz; Hadi Afrasiabi Garekani
Journal:  Iran J Basic Med Sci       Date:  2014-05       Impact factor: 2.699

8.  Relative Contributions of Solubility and Mobility to the Stability of Amorphous Solid Dispersions of Poorly Soluble Drugs: A Molecular Dynamics Simulation Study.

Authors:  Michael Brunsteiner; Johannes Khinast; Amrit Paudel
Journal:  Pharmaceutics       Date:  2018-07-21       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.